Disclosures for "Understanding the Burden of Illness in People with Nonrelapsing Secondary Progressive Multiple Sclerosis in the United States: A Matched-cohort Study"
-
Nupur Greene has nothing to disclose.
-
-
Dr. Hemim has nothing to disclose.
-
Eunice Chang has received personal compensation for serving as an employee of PHAR. Eunice Chang has received research support from Sanofi, which paid PHAR (a health services research consulting company; Eunice Chang is a salaried employee, and salaries are independent of ongoing projects/clients) for research detailed in applicable submitted abstracts. Eunice Chang has received research support from Akcea, Amgen, BioMarin Pharmaceuticals, Bristol-Myers Squibb, Boston Scientific Corporation, Celgene, Delfi Diagnostics, Dompe, Eisai, Exact Sciences Corporation, Genentech, Gilead, GRAIL, Greenwich Biosciences, Ionis, Jazz, Mirum Pharmaceuticals, Nobelpharma, Novartis, Otsuka, Pardes, Prothena, Pfizer, Recordati, Regeneron, Sunovion, Takeda Pharmaceuticals USA, Verde Technologies, which paid PHAR (a health services research consulting company; Eunice Chang is a salaried employee, and salaries are independent of ongoing projects/clients) for research outside of the submitted work.
-
Marian Tarbox has received personal compensation for serving as an employee of PHAR. Marian Tarbox has received research support from Sanofi, which paid PHAR (a health services research consulting company; Marian is a salaried employee, and salaries are independent of ongoing projects/clients) for research detailed in applicable submitted abstracts. Marian Tarbox has received research support from Akcea, Amgen, BioMarin Pharmaceuticals, Bristol-Myers Squibb, Boston Scientific Corporation, Celgene, Delfi Diagnostics, Dompe, Eisai, Exact Sciences Corporation, Genentech, Gilead, GRAIL, Greenwich Biosciences, Ionis, Jazz, Mirum Pharmaceuticals, Nobelpharma, Novartis, Otsuka, Pardes, Prothena, Pfizer, Recordati, Regeneron, Sunovion, Takeda Pharmaceuticals USA, Verde Technologies, which paid PHAR (a health services research consulting company; Marian is a salaried employee, and salaries are independent of ongoing projects/clients) for research outside of the submitted work.
-
Miss Higuchi has received personal compensation for serving as an employee of Sanofi. Miss Higuchi has received personal compensation for serving as an employee of Novartis. Miss Higuchi has received personal compensation for serving as an employee of Gilead Sciences . Miss Higuchi has received personal compensation for serving as an employee of Pfizer Inc. . Miss Higuchi has received personal compensation for serving as an employee of Zynx Health Inc. . Miss Higuchi has received stock or an ownership interest from Sanofi. Miss Higuchi has received stock or an ownership interest from Gilead. Miss Higuchi has received stock or an ownership interest from Novartis.